Elicio Therapeutics Total Liabilities

Elicio Therapeutics (ELTX) currently reports a total liabilities of $24M as of March 2026. That compares with $19M in the prior-year period — up 25.4% year over year. Use the charts on this page to explore Elicio Therapeutics's total liabilities history and peer comparisons.

Elicio Therapeutics's total liabilities increased from $19M to $24M — a 25.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Elicio Therapeutics reported $24M in total liabilities as of March 2026. That compares with $19M in the prior-year period — up 25.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Elicio Therapeutics, and consider following ELTX for alerts when major investors trade the stock.